nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—ADRB1—stomach cancer	0.453	0.543	CbGaD
Esmolol—ADRB2—stomach cancer	0.381	0.457	CbGaD
Esmolol—Ibuprofen—THBD—stomach cancer	0.000668	0.0751	CrCbGaD
Esmolol—Practolol—ADRB1—stomach cancer	0.000488	0.0548	CrCbGaD
Esmolol—Metipranolol—ADRB1—stomach cancer	0.000441	0.0496	CrCbGaD
Esmolol—Sotalol—ADRB1—stomach cancer	0.000393	0.0442	CrCbGaD
Esmolol—Metipranolol—ADRB2—stomach cancer	0.000371	0.0417	CrCbGaD
Esmolol—Bevantolol—ADRB1—stomach cancer	0.000346	0.0389	CrCbGaD
Esmolol—Sotalol—ADRB2—stomach cancer	0.000331	0.0372	CrCbGaD
Esmolol—Betaxolol—ADRB1—stomach cancer	0.000308	0.0347	CrCbGaD
Esmolol—Atenolol—ADRB1—stomach cancer	0.000306	0.0344	CrCbGaD
Esmolol—Bisoprolol—ADRB1—stomach cancer	0.000298	0.0335	CrCbGaD
Esmolol—Bevantolol—ADRB2—stomach cancer	0.000291	0.0327	CrCbGaD
Esmolol—Acebutolol—ADRB1—stomach cancer	0.000282	0.0317	CrCbGaD
Esmolol—Oxprenolol—ADRB1—stomach cancer	0.00028	0.0315	CrCbGaD
Esmolol—Betaxolol—ADRB2—stomach cancer	0.000259	0.0292	CrCbGaD
Esmolol—Atenolol—ADRB2—stomach cancer	0.000257	0.0289	CrCbGaD
Esmolol—Alprenolol—ADRB1—stomach cancer	0.000256	0.0288	CrCbGaD
Esmolol—Bisoprolol—ADRB2—stomach cancer	0.000251	0.0282	CrCbGaD
Esmolol—Metoprolol—ADRB1—stomach cancer	0.000238	0.0268	CrCbGaD
Esmolol—Acebutolol—ADRB2—stomach cancer	0.000237	0.0267	CrCbGaD
Esmolol—Oxprenolol—ADRB2—stomach cancer	0.000236	0.0265	CrCbGaD
Esmolol—Cardiac failure—Doxorubicin—stomach cancer	0.000231	0.00148	CcSEcCtD
Esmolol—Paraesthesia—Irinotecan—stomach cancer	0.00023	0.00148	CcSEcCtD
Esmolol—Hypotension—Fluorouracil—stomach cancer	0.00023	0.00147	CcSEcCtD
Esmolol—Alprenolol—HTR1A—stomach cancer	0.000229	0.0258	CrCbGaD
Esmolol—Dyspnoea—Irinotecan—stomach cancer	0.000229	0.00147	CcSEcCtD
Esmolol—Somnolence—Irinotecan—stomach cancer	0.000228	0.00146	CcSEcCtD
Esmolol—Angiopathy—Docetaxel—stomach cancer	0.000227	0.00145	CcSEcCtD
Esmolol—Dyspepsia—Irinotecan—stomach cancer	0.000226	0.00145	CcSEcCtD
Esmolol—Flushing—Capecitabine—stomach cancer	0.000224	0.00144	CcSEcCtD
Esmolol—Cardiac disorder—Capecitabine—stomach cancer	0.000224	0.00144	CcSEcCtD
Esmolol—Chills—Docetaxel—stomach cancer	0.000224	0.00144	CcSEcCtD
Esmolol—Decreased appetite—Irinotecan—stomach cancer	0.000223	0.00143	CcSEcCtD
Esmolol—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000222	0.00142	CcSEcCtD
Esmolol—Fatigue—Irinotecan—stomach cancer	0.000221	0.00142	CcSEcCtD
Esmolol—Paraesthesia—Fluorouracil—stomach cancer	0.000221	0.00141	CcSEcCtD
Esmolol—Pindolol—ADRB1—stomach cancer	0.00022	0.0248	CrCbGaD
Esmolol—Constipation—Irinotecan—stomach cancer	0.000219	0.00141	CcSEcCtD
Esmolol—Pain—Irinotecan—stomach cancer	0.000219	0.00141	CcSEcCtD
Esmolol—Angiopathy—Capecitabine—stomach cancer	0.000219	0.00141	CcSEcCtD
Esmolol—Dyspnoea—Fluorouracil—stomach cancer	0.000219	0.0014	CcSEcCtD
Esmolol—Mental disorder—Docetaxel—stomach cancer	0.000219	0.0014	CcSEcCtD
Esmolol—Somnolence—Fluorouracil—stomach cancer	0.000219	0.0014	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—stomach cancer	0.000218	0.00139	CcSEcCtD
Esmolol—Erythema—Docetaxel—stomach cancer	0.000217	0.00139	CcSEcCtD
Esmolol—Chills—Capecitabine—stomach cancer	0.000217	0.00139	CcSEcCtD
Esmolol—Dyspepsia—Fluorouracil—stomach cancer	0.000216	0.00139	CcSEcCtD
Esmolol—Abdominal discomfort—Methotrexate—stomach cancer	0.000216	0.00138	CcSEcCtD
Esmolol—Alprenolol—ADRB2—stomach cancer	0.000215	0.0242	CrCbGaD
Esmolol—Cardiac arrest—Doxorubicin—stomach cancer	0.000214	0.00137	CcSEcCtD
Esmolol—Decreased appetite—Fluorouracil—stomach cancer	0.000214	0.00137	CcSEcCtD
Esmolol—Dysgeusia—Docetaxel—stomach cancer	0.000213	0.00136	CcSEcCtD
Esmolol—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000212	0.00136	CcSEcCtD
Esmolol—Mental disorder—Capecitabine—stomach cancer	0.000212	0.00136	CcSEcCtD
Esmolol—Feeling abnormal—Irinotecan—stomach cancer	0.000212	0.00136	CcSEcCtD
Esmolol—Ibuprofen—CXCL8—stomach cancer	0.000211	0.0237	CrCbGaD
Esmolol—Erythema—Capecitabine—stomach cancer	0.00021	0.00135	CcSEcCtD
Esmolol—Dysuria—Methotrexate—stomach cancer	0.00021	0.00135	CcSEcCtD
Esmolol—Pain—Fluorouracil—stomach cancer	0.00021	0.00135	CcSEcCtD
Esmolol—Dysgeusia—Capecitabine—stomach cancer	0.000206	0.00132	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—stomach cancer	0.000205	0.00131	CcSEcCtD
Esmolol—Body temperature increased—Irinotecan—stomach cancer	0.000203	0.0013	CcSEcCtD
Esmolol—Feeling abnormal—Fluorouracil—stomach cancer	0.000203	0.0013	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—stomach cancer	0.000201	0.00129	CcSEcCtD
Esmolol—Drowsiness—Methotrexate—stomach cancer	0.000201	0.00128	CcSEcCtD
Esmolol—Metoprolol—ADRB2—stomach cancer	0.0002	0.0225	CrCbGaD
Esmolol—Pindolol—HTR1A—stomach cancer	0.000197	0.0222	CrCbGaD
Esmolol—Dysuria—Epirubicin—stomach cancer	0.000197	0.00126	CcSEcCtD
Esmolol—Urticaria—Fluorouracil—stomach cancer	0.000195	0.00125	CcSEcCtD
Esmolol—Syncope—Docetaxel—stomach cancer	0.000195	0.00125	CcSEcCtD
Esmolol—Body temperature increased—Fluorouracil—stomach cancer	0.000194	0.00125	CcSEcCtD
Esmolol—Loss of consciousness—Docetaxel—stomach cancer	0.000191	0.00122	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—stomach cancer	0.00019	0.00122	CcSEcCtD
Esmolol—Syncope—Capecitabine—stomach cancer	0.000189	0.00121	CcSEcCtD
Esmolol—Convulsion—Docetaxel—stomach cancer	0.000188	0.00121	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—stomach cancer	0.000188	0.0012	CcSEcCtD
Esmolol—Pindolol—ADRB2—stomach cancer	0.000185	0.0208	CrCbGaD
Esmolol—Chest pain—Docetaxel—stomach cancer	0.000185	0.00119	CcSEcCtD
Esmolol—Loss of consciousness—Capecitabine—stomach cancer	0.000185	0.00119	CcSEcCtD
Esmolol—Asthenia—Irinotecan—stomach cancer	0.000184	0.00118	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—stomach cancer	0.000184	0.00118	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000184	0.00118	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—stomach cancer	0.000182	0.00117	CcSEcCtD
Esmolol—Dry mouth—Docetaxel—stomach cancer	0.000181	0.00116	CcSEcCtD
Esmolol—Chest pain—Capecitabine—stomach cancer	0.000179	0.00115	CcSEcCtD
Esmolol—Confusional state—Docetaxel—stomach cancer	0.000179	0.00115	CcSEcCtD
Esmolol—Pharyngitis—Methotrexate—stomach cancer	0.000179	0.00114	CcSEcCtD
Esmolol—Anxiety—Capecitabine—stomach cancer	0.000179	0.00114	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000178	0.00114	CcSEcCtD
Esmolol—Urinary tract disorder—Methotrexate—stomach cancer	0.000178	0.00114	CcSEcCtD
Esmolol—Oedema—Docetaxel—stomach cancer	0.000177	0.00114	CcSEcCtD
Esmolol—Urethral disorder—Methotrexate—stomach cancer	0.000176	0.00113	CcSEcCtD
Esmolol—Propafenone—ADRB1—stomach cancer	0.000176	0.0197	CrCbGaD
Esmolol—Dry mouth—Capecitabine—stomach cancer	0.000175	0.00112	CcSEcCtD
Esmolol—Shock—Docetaxel—stomach cancer	0.000175	0.00112	CcSEcCtD
Esmolol—Nervous system disorder—Docetaxel—stomach cancer	0.000174	0.00111	CcSEcCtD
Esmolol—Pruritus—Fluorouracil—stomach cancer	0.000174	0.00111	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—stomach cancer	0.000174	0.00111	CcSEcCtD
Esmolol—Visual impairment—Methotrexate—stomach cancer	0.000173	0.00111	CcSEcCtD
Esmolol—Confusional state—Capecitabine—stomach cancer	0.000173	0.00111	CcSEcCtD
Esmolol—Skin disorder—Docetaxel—stomach cancer	0.000172	0.0011	CcSEcCtD
Esmolol—Oedema—Capecitabine—stomach cancer	0.000172	0.0011	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—stomach cancer	0.000171	0.0011	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—stomach cancer	0.00017	0.00109	CcSEcCtD
Esmolol—Dizziness—Irinotecan—stomach cancer	0.00017	0.00109	CcSEcCtD
Esmolol—Anorexia—Docetaxel—stomach cancer	0.000169	0.00108	CcSEcCtD
Esmolol—Shock—Capecitabine—stomach cancer	0.000169	0.00108	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—stomach cancer	0.000169	0.00108	CcSEcCtD
Esmolol—Nervous system disorder—Capecitabine—stomach cancer	0.000168	0.00108	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—stomach cancer	0.000167	0.00107	CcSEcCtD
Esmolol—Cardiac disorder—Methotrexate—stomach cancer	0.000167	0.00107	CcSEcCtD
Esmolol—Skin disorder—Capecitabine—stomach cancer	0.000167	0.00107	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—stomach cancer	0.000166	0.00107	CcSEcCtD
Esmolol—Hyperhidrosis—Capecitabine—stomach cancer	0.000166	0.00106	CcSEcCtD
Esmolol—Hypotension—Docetaxel—stomach cancer	0.000166	0.00106	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—stomach cancer	0.000165	0.00106	CcSEcCtD
Esmolol—Anorexia—Capecitabine—stomach cancer	0.000164	0.00105	CcSEcCtD
Esmolol—Angiopathy—Methotrexate—stomach cancer	0.000163	0.00105	CcSEcCtD
Esmolol—Vomiting—Irinotecan—stomach cancer	0.000163	0.00105	CcSEcCtD
Esmolol—Dizziness—Fluorouracil—stomach cancer	0.000163	0.00104	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—stomach cancer	0.000162	0.00104	CcSEcCtD
Esmolol—Chills—Methotrexate—stomach cancer	0.000162	0.00103	CcSEcCtD
Esmolol—Headache—Irinotecan—stomach cancer	0.000161	0.00103	CcSEcCtD
Esmolol—Hypotension—Capecitabine—stomach cancer	0.000161	0.00103	CcSEcCtD
Esmolol—Paraesthesia—Docetaxel—stomach cancer	0.000159	0.00102	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—stomach cancer	0.000159	0.00102	CcSEcCtD
Esmolol—Dyspnoea—Docetaxel—stomach cancer	0.000158	0.00101	CcSEcCtD
Esmolol—Somnolence—Docetaxel—stomach cancer	0.000158	0.00101	CcSEcCtD
Esmolol—Mental disorder—Methotrexate—stomach cancer	0.000158	0.00101	CcSEcCtD
Esmolol—Erythema—Methotrexate—stomach cancer	0.000157	0.001	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—stomach cancer	0.000156	0.001	CcSEcCtD
Esmolol—Flushing—Epirubicin—stomach cancer	0.000156	0.001	CcSEcCtD
Esmolol—Vomiting—Fluorouracil—stomach cancer	0.000156	0.001	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—stomach cancer	0.000156	0.001	CcSEcCtD
Esmolol—Dyspepsia—Docetaxel—stomach cancer	0.000156	0.001	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—stomach cancer	0.000155	0.000991	CcSEcCtD
Esmolol—Paraesthesia—Capecitabine—stomach cancer	0.000154	0.000988	CcSEcCtD
Esmolol—Decreased appetite—Docetaxel—stomach cancer	0.000154	0.000988	CcSEcCtD
Esmolol—Headache—Fluorouracil—stomach cancer	0.000154	0.000987	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—stomach cancer	0.000154	0.000986	CcSEcCtD
Esmolol—Dysgeusia—Methotrexate—stomach cancer	0.000153	0.000983	CcSEcCtD
Esmolol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000153	0.000981	CcSEcCtD
Esmolol—Dyspnoea—Capecitabine—stomach cancer	0.000153	0.000981	CcSEcCtD
Esmolol—Fatigue—Docetaxel—stomach cancer	0.000153	0.00098	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—stomach cancer	0.000153	0.000979	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—stomach cancer	0.000153	0.000979	CcSEcCtD
Esmolol—Nausea—Irinotecan—stomach cancer	0.000152	0.000977	CcSEcCtD
Esmolol—Constipation—Docetaxel—stomach cancer	0.000152	0.000972	CcSEcCtD
Esmolol—Pain—Docetaxel—stomach cancer	0.000152	0.000972	CcSEcCtD
Esmolol—Dyspepsia—Capecitabine—stomach cancer	0.000151	0.000969	CcSEcCtD
Esmolol—Chills—Epirubicin—stomach cancer	0.000151	0.000968	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—stomach cancer	0.00015	0.000962	CcSEcCtD
Esmolol—Decreased appetite—Capecitabine—stomach cancer	0.000149	0.000957	CcSEcCtD
Esmolol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000148	0.00095	CcSEcCtD
Esmolol—Fatigue—Capecitabine—stomach cancer	0.000148	0.000949	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—stomach cancer	0.000148	0.000945	CcSEcCtD
Esmolol—Pain—Capecitabine—stomach cancer	0.000147	0.000941	CcSEcCtD
Esmolol—Constipation—Capecitabine—stomach cancer	0.000147	0.000941	CcSEcCtD
Esmolol—Erythema—Epirubicin—stomach cancer	0.000147	0.000939	CcSEcCtD
Esmolol—Feeling abnormal—Docetaxel—stomach cancer	0.000146	0.000937	CcSEcCtD
Esmolol—Nausea—Fluorouracil—stomach cancer	0.000146	0.000935	CcSEcCtD
Esmolol—Ibuprofen—PPARG—stomach cancer	0.000146	0.0164	CrCbGaD
Esmolol—Flushing—Doxorubicin—stomach cancer	0.000145	0.000927	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—stomach cancer	0.000145	0.000927	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—stomach cancer	0.000144	0.00092	CcSEcCtD
Esmolol—Feeling abnormal—Capecitabine—stomach cancer	0.000142	0.000907	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—stomach cancer	0.000141	0.000906	CcSEcCtD
Esmolol—Body temperature increased—Docetaxel—stomach cancer	0.00014	0.000899	CcSEcCtD
Esmolol—Chills—Doxorubicin—stomach cancer	0.00014	0.000896	CcSEcCtD
Esmolol—Chlorphenesin—PTGS2—stomach cancer	0.000138	0.0155	CrCbGaD
Esmolol—Mental disorder—Doxorubicin—stomach cancer	0.000137	0.000875	CcSEcCtD
Esmolol—Urticaria—Capecitabine—stomach cancer	0.000136	0.000874	CcSEcCtD
Esmolol—Body temperature increased—Capecitabine—stomach cancer	0.000136	0.00087	CcSEcCtD
Esmolol—Convulsion—Methotrexate—stomach cancer	0.000136	0.00087	CcSEcCtD
Esmolol—Erythema—Doxorubicin—stomach cancer	0.000136	0.000869	CcSEcCtD
Esmolol—Agitation—Epirubicin—stomach cancer	0.000135	0.000863	CcSEcCtD
Esmolol—Chest pain—Methotrexate—stomach cancer	0.000133	0.000855	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—stomach cancer	0.000133	0.000851	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000132	0.000849	CcSEcCtD
Esmolol—Syncope—Epirubicin—stomach cancer	0.000131	0.000842	CcSEcCtD
Esmolol—Confusional state—Methotrexate—stomach cancer	0.000129	0.000826	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—stomach cancer	0.000129	0.000826	CcSEcCtD
Esmolol—Asthenia—Docetaxel—stomach cancer	0.000127	0.000816	CcSEcCtD
Esmolol—Convulsion—Epirubicin—stomach cancer	0.000127	0.000814	CcSEcCtD
Esmolol—Pruritus—Docetaxel—stomach cancer	0.000126	0.000804	CcSEcCtD
Esmolol—Nervous system disorder—Methotrexate—stomach cancer	0.000125	0.000803	CcSEcCtD
Esmolol—Chest pain—Epirubicin—stomach cancer	0.000125	0.0008	CcSEcCtD
Esmolol—Agitation—Doxorubicin—stomach cancer	0.000125	0.000799	CcSEcCtD
Esmolol—Anxiety—Epirubicin—stomach cancer	0.000124	0.000797	CcSEcCtD
Esmolol—Skin disorder—Methotrexate—stomach cancer	0.000124	0.000796	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000124	0.000794	CcSEcCtD
Esmolol—Hyperhidrosis—Methotrexate—stomach cancer	0.000124	0.000792	CcSEcCtD
Esmolol—Asthenia—Capecitabine—stomach cancer	0.000123	0.00079	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—stomach cancer	0.000122	0.000782	CcSEcCtD
Esmolol—Anorexia—Methotrexate—stomach cancer	0.000122	0.000781	CcSEcCtD
Esmolol—Syncope—Doxorubicin—stomach cancer	0.000122	0.00078	CcSEcCtD
Esmolol—Pruritus—Capecitabine—stomach cancer	0.000122	0.000779	CcSEcCtD
Esmolol—Confusional state—Epirubicin—stomach cancer	0.000121	0.000773	CcSEcCtD
Esmolol—Propranolol—ADRB1—stomach cancer	0.00012	0.0135	CrCbGaD
Esmolol—Oedema—Epirubicin—stomach cancer	0.00012	0.000767	CcSEcCtD
Esmolol—Hypotension—Methotrexate—stomach cancer	0.000119	0.000766	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—stomach cancer	0.000119	0.000764	CcSEcCtD
Esmolol—Shock—Epirubicin—stomach cancer	0.000118	0.000754	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—stomach cancer	0.000118	0.000753	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—stomach cancer	0.000117	0.000752	CcSEcCtD
Esmolol—Dizziness—Docetaxel—stomach cancer	0.000117	0.000752	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—stomach cancer	0.000116	0.000745	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—stomach cancer	0.000116	0.000741	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—stomach cancer	0.000116	0.00074	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—stomach cancer	0.000115	0.000737	CcSEcCtD
Esmolol—Paraesthesia—Methotrexate—stomach cancer	0.000115	0.000736	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000115	0.000735	CcSEcCtD
Esmolol—Anorexia—Epirubicin—stomach cancer	0.000114	0.000731	CcSEcCtD
Esmolol—Dyspnoea—Methotrexate—stomach cancer	0.000114	0.00073	CcSEcCtD
Esmolol—Somnolence—Methotrexate—stomach cancer	0.000114	0.000728	CcSEcCtD
Esmolol—Dizziness—Capecitabine—stomach cancer	0.000114	0.000728	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—stomach cancer	0.000113	0.000724	CcSEcCtD
Esmolol—Vomiting—Docetaxel—stomach cancer	0.000113	0.000723	CcSEcCtD
Esmolol—Dyspepsia—Methotrexate—stomach cancer	0.000113	0.000721	CcSEcCtD
Esmolol—Hypotension—Epirubicin—stomach cancer	0.000112	0.000716	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—stomach cancer	0.000112	0.000715	CcSEcCtD
Esmolol—Decreased appetite—Methotrexate—stomach cancer	0.000111	0.000712	CcSEcCtD
Esmolol—Headache—Docetaxel—stomach cancer	0.000111	0.000712	CcSEcCtD
Esmolol—Oedema—Doxorubicin—stomach cancer	0.000111	0.000709	CcSEcCtD
Esmolol—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00011	0.000707	CcSEcCtD
Esmolol—Fatigue—Methotrexate—stomach cancer	0.00011	0.000706	CcSEcCtD
Esmolol—Pain—Methotrexate—stomach cancer	0.000109	0.000701	CcSEcCtD
Esmolol—Vomiting—Capecitabine—stomach cancer	0.000109	0.0007	CcSEcCtD
Esmolol—Shock—Doxorubicin—stomach cancer	0.000109	0.000698	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—stomach cancer	0.000109	0.000696	CcSEcCtD
Esmolol—Headache—Capecitabine—stomach cancer	0.000108	0.000689	CcSEcCtD
Esmolol—Propranolol—HTR1A—stomach cancer	0.000108	0.0121	CrCbGaD
Esmolol—Skin disorder—Doxorubicin—stomach cancer	0.000108	0.000689	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—stomach cancer	0.000107	0.000688	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000107	0.000686	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—stomach cancer	0.000107	0.000684	CcSEcCtD
Esmolol—Somnolence—Epirubicin—stomach cancer	0.000106	0.000682	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—stomach cancer	0.000106	0.000676	CcSEcCtD
Esmolol—Nausea—Docetaxel—stomach cancer	0.000105	0.000675	CcSEcCtD
Esmolol—Feeling abnormal—Methotrexate—stomach cancer	0.000105	0.000675	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—stomach cancer	0.000105	0.000675	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—stomach cancer	0.000104	0.000667	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—stomach cancer	0.000103	0.000663	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000103	0.000662	CcSEcCtD
Esmolol—Fatigue—Epirubicin—stomach cancer	0.000103	0.000661	CcSEcCtD
Esmolol—Pain—Epirubicin—stomach cancer	0.000102	0.000656	CcSEcCtD
Esmolol—Constipation—Epirubicin—stomach cancer	0.000102	0.000656	CcSEcCtD
Esmolol—Nausea—Capecitabine—stomach cancer	0.000102	0.000654	CcSEcCtD
Esmolol—Urticaria—Methotrexate—stomach cancer	0.000102	0.000651	CcSEcCtD
Esmolol—Propranolol—ADRB2—stomach cancer	0.000101	0.0114	CrCbGaD
Esmolol—Body temperature increased—Methotrexate—stomach cancer	0.000101	0.000648	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—stomach cancer	9.94e-05	0.000637	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—stomach cancer	9.87e-05	0.000632	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—stomach cancer	9.86e-05	0.000632	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—stomach cancer	9.84e-05	0.000631	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—stomach cancer	9.75e-05	0.000624	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—stomach cancer	9.63e-05	0.000617	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.56e-05	0.000612	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—stomach cancer	9.55e-05	0.000612	CcSEcCtD
Esmolol—Urticaria—Epirubicin—stomach cancer	9.51e-05	0.000609	CcSEcCtD
Esmolol—Pain—Doxorubicin—stomach cancer	9.47e-05	0.000607	CcSEcCtD
Esmolol—Constipation—Doxorubicin—stomach cancer	9.47e-05	0.000607	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—stomach cancer	9.46e-05	0.000606	CcSEcCtD
Esmolol—Asthenia—Methotrexate—stomach cancer	9.18e-05	0.000588	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—stomach cancer	9.12e-05	0.000585	CcSEcCtD
Esmolol—Pruritus—Methotrexate—stomach cancer	9.05e-05	0.00058	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—stomach cancer	8.8e-05	0.000564	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—stomach cancer	8.75e-05	0.000561	CcSEcCtD
Esmolol—Asthenia—Epirubicin—stomach cancer	8.59e-05	0.00055	CcSEcCtD
Esmolol—Pruritus—Epirubicin—stomach cancer	8.47e-05	0.000542	CcSEcCtD
Esmolol—Dizziness—Methotrexate—stomach cancer	8.46e-05	0.000542	CcSEcCtD
Esmolol—Vomiting—Methotrexate—stomach cancer	8.13e-05	0.000521	CcSEcCtD
Esmolol—Headache—Methotrexate—stomach cancer	8.01e-05	0.000513	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—stomach cancer	7.94e-05	0.000509	CcSEcCtD
Esmolol—Dizziness—Epirubicin—stomach cancer	7.91e-05	0.000507	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—stomach cancer	7.83e-05	0.000502	CcSEcCtD
Esmolol—Vomiting—Epirubicin—stomach cancer	7.61e-05	0.000487	CcSEcCtD
Esmolol—Nausea—Methotrexate—stomach cancer	7.6e-05	0.000487	CcSEcCtD
Esmolol—Headache—Epirubicin—stomach cancer	7.5e-05	0.00048	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—stomach cancer	7.32e-05	0.000469	CcSEcCtD
Esmolol—Nausea—Epirubicin—stomach cancer	7.11e-05	0.000455	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—stomach cancer	7.04e-05	0.000451	CcSEcCtD
Esmolol—Headache—Doxorubicin—stomach cancer	6.94e-05	0.000444	CcSEcCtD
Esmolol—Nausea—Doxorubicin—stomach cancer	6.58e-05	0.000421	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—stomach cancer	6.15e-05	0.00691	CrCbGaD
Esmolol—Ibuprofen—ALB—stomach cancer	5.48e-05	0.00616	CrCbGaD
Esmolol—ADRB2—Arf6 signaling events—MET—stomach cancer	8.73e-06	0.0129	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Other—F2R—stomach cancer	7.91e-06	0.0117	CbGpPWpGaD
Esmolol—ADRB1—Endothelin Pathways—NOS3—stomach cancer	7.31e-06	0.0108	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	7.27e-06	0.0108	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	7.25e-06	0.0107	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	7.12e-06	0.0105	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	7.09e-06	0.0105	CbGpPWpGaD
Esmolol—ADRB2—Arf6 trafficking events—CDH1—stomach cancer	5.98e-06	0.00885	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—ADRB1—stomach cancer	5.62e-06	0.00833	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—KISS1R—stomach cancer	5.52e-06	0.00818	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—KISS1R—stomach cancer	5.4e-06	0.008	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	5.24e-06	0.00776	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	5.13e-06	0.00759	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—stomach cancer	4.86e-06	0.00719	CbGpPWpGaD
Esmolol—ADRB1—Endothelin Pathways—MAPK1—stomach cancer	4.74e-06	0.00702	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	4.67e-06	0.00692	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—ADRB2—stomach cancer	4.66e-06	0.0069	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	4.57e-06	0.00677	CbGpPWpGaD
Esmolol—ADRB2—Arf6 signaling events—EGFR—stomach cancer	4.42e-06	0.00655	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—stomach cancer	4.02e-06	0.00596	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—HRH4—stomach cancer	3.99e-06	0.00591	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—HRH4—stomach cancer	3.9e-06	0.00578	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—KISS1—stomach cancer	3.56e-06	0.00527	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	3.55e-06	0.00526	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	3.51e-06	0.0052	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—KISS1—stomach cancer	3.48e-06	0.00515	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	3.48e-06	0.00515	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	3.44e-06	0.00509	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	3.42e-06	0.00507	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	3.35e-06	0.00496	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	3.13e-06	0.00464	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—KISS1R—stomach cancer	3.12e-06	0.00462	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—KISS1R—stomach cancer	3.05e-06	0.00452	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	3.04e-06	0.00451	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	3.01e-06	0.00446	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	2.98e-06	0.00441	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	2.94e-06	0.00436	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	2.93e-06	0.00434	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	2.87e-06	0.00425	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—KISS1R—stomach cancer	2.83e-06	0.0042	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	2.83e-06	0.00419	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—KISS1R—stomach cancer	2.77e-06	0.0041	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	2.77e-06	0.0041	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	2.76e-06	0.00408	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	2.7e-06	0.00399	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	2.68e-06	0.00397	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	2.59e-06	0.00384	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—AGTR2—stomach cancer	2.32e-06	0.00343	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—F2R—stomach cancer	2.29e-06	0.0034	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—AGTR2—stomach cancer	2.27e-06	0.00336	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HRH4—stomach cancer	2.26e-06	0.00334	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—F2R—stomach cancer	2.24e-06	0.00332	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—HTR1A—stomach cancer	2.23e-06	0.00331	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	2.22e-06	0.00329	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HRH4—stomach cancer	2.21e-06	0.00327	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—HTR1A—stomach cancer	2.18e-06	0.00323	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—ANXA1—stomach cancer	2.16e-06	0.00319	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—ANXA1—stomach cancer	2.11e-06	0.00312	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HRH4—stomach cancer	2.05e-06	0.00303	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—ADRB1—stomach cancer	2.04e-06	0.00302	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—KISS1—stomach cancer	2.01e-06	0.00298	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HRH4—stomach cancer	2e-06	0.00297	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—KISS1—stomach cancer	1.97e-06	0.00291	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—KISS1—stomach cancer	1.83e-06	0.0027	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—KISS1—stomach cancer	1.79e-06	0.00265	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—RGS2—stomach cancer	1.73e-06	0.00256	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GAST—stomach cancer	1.73e-06	0.00256	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—ADRB2—stomach cancer	1.69e-06	0.0025	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GAST—stomach cancer	1.69e-06	0.0025	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—RGS2—stomach cancer	1.69e-06	0.0025	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GLI3—stomach cancer	1.67e-06	0.00248	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KISS1R—stomach cancer	1.67e-06	0.00248	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GLI3—stomach cancer	1.64e-06	0.00242	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KISS1R—stomach cancer	1.64e-06	0.00242	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RBP1—stomach cancer	1.6e-06	0.00236	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GAST—stomach cancer	1.57e-06	0.00233	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—RGS2—stomach cancer	1.57e-06	0.00233	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RBP1—stomach cancer	1.56e-06	0.00231	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GAST—stomach cancer	1.54e-06	0.00227	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RGS2—stomach cancer	1.54e-06	0.00227	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGTR2—stomach cancer	1.31e-06	0.00194	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—WWOX—stomach cancer	1.3e-06	0.00193	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—F2R—stomach cancer	1.3e-06	0.00192	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGTR2—stomach cancer	1.28e-06	0.0019	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—WWOX—stomach cancer	1.27e-06	0.00189	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—F2R—stomach cancer	1.27e-06	0.00188	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HTR1A—stomach cancer	1.26e-06	0.00187	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HTR1A—stomach cancer	1.23e-06	0.00183	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ANXA1—stomach cancer	1.22e-06	0.0018	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—WIF1—stomach cancer	1.21e-06	0.00179	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HRH4—stomach cancer	1.21e-06	0.00179	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ANXA1—stomach cancer	1.19e-06	0.00176	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGTR2—stomach cancer	1.19e-06	0.00176	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HRH4—stomach cancer	1.18e-06	0.00175	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—WIF1—stomach cancer	1.18e-06	0.00175	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—F2R—stomach cancer	1.18e-06	0.00174	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	1.16e-06	0.00172	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	1.15e-06	0.00171	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—F2R—stomach cancer	1.15e-06	0.0017	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	1.15e-06	0.0017	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	1.12e-06	0.00166	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	1.12e-06	0.00165	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	1.11e-06	0.00164	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	1.09e-06	0.00162	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	1.08e-06	0.0016	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	1.08e-06	0.0016	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	1.08e-06	0.0016	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	1.07e-06	0.00159	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	1.05e-06	0.00156	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	1.05e-06	0.00156	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	1.05e-06	0.00155	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	1.05e-06	0.00155	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FST—stomach cancer	9.61e-07	0.00142	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	9.56e-07	0.00142	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	9.4e-07	0.00139	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FST—stomach cancer	9.4e-07	0.00139	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GAST—stomach cancer	9.27e-07	0.00137	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	9.27e-07	0.00137	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	9.2e-07	0.00136	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	9.07e-07	0.00134	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GAST—stomach cancer	9.07e-07	0.00134	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGG—stomach cancer	8.79e-07	0.0013	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	8.68e-07	0.00129	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGG—stomach cancer	8.6e-07	0.00127	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	8.5e-07	0.00126	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	8.46e-07	0.00125	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	8.32e-07	0.00123	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	8.28e-07	0.00123	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	8.17e-07	0.00121	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	8.17e-07	0.00121	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	7.99e-07	0.00118	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	7.99e-07	0.00118	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	7.03e-07	0.00104	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	7.03e-07	0.00104	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—F2R—stomach cancer	6.95e-07	0.00103	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	6.95e-07	0.00103	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	6.87e-07	0.00102	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	6.87e-07	0.00102	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	6.84e-07	0.00101	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	6.8e-07	0.00101	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—F2R—stomach cancer	6.8e-07	0.00101	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	6.76e-07	0.001	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	6.69e-07	0.000991	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	6.62e-07	0.00098	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	6.55e-07	0.00097	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	6.53e-07	0.000968	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	6.41e-07	0.000949	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	6.39e-07	0.000947	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	6.19e-07	0.000917	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	6.05e-07	0.000895	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	5.95e-07	0.000881	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	5.92e-07	0.000878	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	5.91e-07	0.000876	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	5.82e-07	0.000862	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	5.8e-07	0.000858	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	5.56e-07	0.000823	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	5.43e-07	0.000805	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	5.29e-07	0.000783	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	5.26e-07	0.000779	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	5.17e-07	0.000766	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	5.14e-07	0.000762	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	5.13e-07	0.000759	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	5.02e-07	0.000744	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	4.91e-07	0.000728	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	4.77e-07	0.000707	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	4.67e-07	0.000692	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	4.66e-07	0.000691	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	4.62e-07	0.000684	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	4.56e-07	0.000676	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	4.52e-07	0.000669	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FYN—stomach cancer	4.43e-07	0.000656	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FYN—stomach cancer	4.33e-07	0.000642	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	4.19e-07	0.000621	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	4.16e-07	0.000616	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	4.1e-07	0.000607	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	4.07e-07	0.000602	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	3.81e-07	0.000564	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	3.72e-07	0.000552	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	3.69e-07	0.000547	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	3.68e-07	0.000546	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	3.61e-07	0.000535	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	3.6e-07	0.000534	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	3.51e-07	0.00052	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	3.5e-07	0.000518	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	3.44e-07	0.000509	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	3.42e-07	0.000507	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APC—stomach cancer	3.36e-07	0.000498	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APC—stomach cancer	3.29e-07	0.000487	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	3.22e-07	0.000477	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	3.15e-07	0.000467	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	3.12e-07	0.000462	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	3.06e-07	0.000454	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	3.06e-07	0.000454	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	3.05e-07	0.000452	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	3e-07	0.000444	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	3e-07	0.000444	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	2.93e-07	0.000434	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	2.92e-07	0.000433	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	2.89e-07	0.000429	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	2.86e-07	0.000424	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	2.86e-07	0.000424	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	2.83e-07	0.000419	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	2.82e-07	0.000418	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	2.79e-07	0.000413	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	2.76e-07	0.000409	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	2.73e-07	0.000404	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	2.66e-07	0.000394	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	2.61e-07	0.000387	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	2.6e-07	0.000385	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	2.55e-07	0.000378	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	2.48e-07	0.000367	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	2.46e-07	0.000364	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	2.42e-07	0.000359	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	2.42e-07	0.000358	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	2.41e-07	0.000356	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	2.37e-07	0.00035	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	2.35e-07	0.000349	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	2.31e-07	0.000342	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	2.3e-07	0.000341	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JUN—stomach cancer	2.3e-07	0.000341	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	2.26e-07	0.000334	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JUN—stomach cancer	2.25e-07	0.000334	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	2.24e-07	0.000332	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	2.23e-07	0.000331	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	2.19e-07	0.000325	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	2.18e-07	0.000323	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	2.18e-07	0.000323	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	2.13e-07	0.000316	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.01e-07	0.000298	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	1.99e-07	0.000295	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	1.97e-07	0.000291	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	1.95e-07	0.000289	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	1.9e-07	0.000282	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	1.86e-07	0.000276	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MYC—stomach cancer	1.85e-07	0.000274	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	1.81e-07	0.000268	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MYC—stomach cancer	1.81e-07	0.000268	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	1.81e-07	0.000268	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	1.77e-07	0.000262	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	1.77e-07	0.000262	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	1.71e-07	0.000253	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	1.67e-07	0.000248	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	1.57e-07	0.000233	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	1.54e-07	0.000228	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TP53—stomach cancer	1.52e-07	0.000225	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TP53—stomach cancer	1.49e-07	0.00022	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	1.45e-07	0.000215	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	1.42e-07	0.000211	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6—stomach cancer	1.39e-07	0.000206	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6—stomach cancer	1.36e-07	0.000202	CbGpPWpGaD
